U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104877) titled 'A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors' on July 29.
Brief Summary: This study is an open-label, non-randomized trial design, including a dose escalation phase and a dose expansion phase, to evaluate the safety, tolerability and preliminary anti-tumor activity of SYS6010 in combination with SYH2051 in patients with advanced gastrointestinal tumors.
Study Start Date: April 18, 2024
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Gastric Cancer (GC)
Gastrointestinal Tumors
Intervention:
DRUG: SYS6010
Administered via intravenous infusion...